Impact of renal function and demographic/anthropomorphic variables on peak thyrotropin after recombinant human thyrotropin stimulation: A stepwise forward multiple-regression analysis

Thyroid

Volumn 23, Issue 6, 2013, Pages 662-670

  Hautzel, Hubertus ^a   Pisar, Elisabeth ^a   Lindner, David ^a   Schott, Matthias ^a   Grandt, Rüdiger ^a   Müller, Hans Wilhelm ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; RECOMBINANT THYROTROPIN; THYROTROPIN; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY SURFACE; BODY WEIGHT; CALCULATION; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIFFERENTIATED THYROID CANCER; EFFECT SIZE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INDEPENDENT VARIABLE; INDIVIDUALIZATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SEX DIFFERENCE; THYROTROPIN BLOOD LEVEL; BLOOD; COMPLICATION; DIAGNOSTIC USE; DRUG EFFECTS; HYPOTHYROIDISM; KIDNEY; KIDNEY FAILURE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; THYROID GLAND; THYROID NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY SURFACE AREA; FEMALE; HUMANS; HYPOTHYROIDISM; KIDNEY; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; RECOMBINANT PROTEINS; REGRESSION ANALYSIS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; THYROID GLAND; THYROID NEOPLASMS; THYROTROPIN; YOUNG ADULT;

EID: 84878840051     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0284     Document Type: Article

References (23)

1. Dietlein M, Busemeyer S, Kobe C, Schmidt M, Theissen P, Schicha H 2010 Recombinant human TSH versus hypothyroidism. Cost-minimization-Analysis in the follow-up care of differentiated thyroid carcinoma. Nuklearmedizin 49:216-224.
2. Lee J, Yun MJ, Nam KH, Chung WY, Soh EY, Park CS 2010 Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma. Thyroid 20:173-179.
3. Heinzel A, Kley K, Mueller HW, Hautzel H 2012 A comparison of rh-TSH and thyroid hormone withdrawal in patients with differentiated thyroid cancer: preliminary evidence for an influence of age on the subjective well-being in hypothyroidism. Horm Metab Res 44:54-59.
4. Product Information 2008 Thyrogen, Thyrotropin Alfa for Injection. Genzyme Corporation, Cambridge, MA.
5. Cuttelod S, Lemarchand-Beraud T, Magnenat P, Perret C, Poli S, Vannotti A 1974 Effect of age and role of kidneys and liver on thyrotropin turnover in man. Metabolism 23: 101-113.
6. Mariotti S 1996 Normal physiology of the hypothalmicpituitary thyroidal system, and relation to the neural system and other endocrine glands. In: DeGroot LJ, Larsen PR, Hennemann G (eds) The Thyroid and Its Diseases, 6th edition. John Wiley & Sons, New York, pp 118-163.
7. Thotakura NR, Desai RK, Bates LG, Cole ES, Pratt BM, Weintraub BD 1991 Biological activity and metabolic clearance of a recombinant human thyrotropin produced in Chinese hamster ovary cells. Endocrinology 128:341-348.
8. Constant RB, Weintraub BD 1986 Differences in the metabolic clearance of pituitary and serum thyrotropin (TSH) derived from euthyroid and hypothyroid rats: effects of chemical deglycosylation of pituitary TSH. Endocrinology 119:2720-2727.
9. Bakke J, Lawrence N, Roy S 1962 Disappearance rate of exogenous thyroid-stimulating hormone (TSH) in man. J Clin Endocrinol Metab 22:352-363.
10. Castagna MG, Pinchera A, Marsili A, Giannetti M, Molinaro E, Fierabracci P, Grasso L, Pacini F, Santini F, Elisei R 2005 Influence of human body composition on serum peak thyrotropin (TSH) after recombinant human TSH administration in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 90:4047-4050.
11. Montesano T, Durante C, Attard M, Crocetti U, Meringolo D, Bruno R, Tumino S, Rubello D, Al-Nahhas A, Colandrea M, Maranghi M, Travascio L, Ronga G, Torlontano M 2007 Age influences TSH serum levels after withdrawal of lthyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer. Biomed Pharmacother 61:468-471.
12. Over R, Nsouli-Maktabi H, Burman KD, Jonklaas J 2010 Age modifies the response to recombinant human thyrotropin. Thyroid 20:1377-1384.
13. Vitale G, Lupoli GA, Ciccarelli A, Lucariello A, Fittipaldi MR, Fonderico F, Panico A, Lupoli G 2003 Influence of body surface area on serum peak thyrotropin (TSH) levels after recombinant human TSH administration. J Clin Endocrinol Metab 88:1319-1322.
14. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van LF 2006 Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247-254.
15. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803.
16. Dietlein M, Dressler J, Eschner W, Grunwald F, Lassmann M, Leisner B, Luster M, Moser E, Reiners C, Schicha H, Schober O 2007 [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)]. Nuklearmedizin 46:213-219.
17. Dietlein M, Dressler J, Eschner W, Grunwald F, Lassmann M, Leisner B, Luster M, Reiners C, Schicha H, Schober O 2007 [Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 3)]. Nuklearmedizin 46:206-212.
18. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
19. Torres MS, Ramirez L, Simkin PH, Braverman LE, Emerson CH 2001 Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects. J Clin Endocrinol Metab 86:1660-1664.
20. Pitoia F, Ilera V, Zanchetta MB, Foffano A, Niepomniszcze H 2008 Optimum recombinant human thyrotropin dose in patients with differentiated thyroid carcinoma and endstage renal disease. Endocr Pract 14:961-966.
21. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, Hostetter T, Levey AS, Panteghini M, Welch M, Eckfeldt JH 2006 Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 52:5-18.
22. Wells JC 2007 Sexual dimorphism of body composition. Best Pract Res Clin Endocrinol Metab 21:415-430.
23. Thyroid TNM Classification 2010 In: Edge SB, Byrd DR, Compton CC (eds) AJCC Cancer Staging Manual, 7th edition. Springer, New York, Chapter 8: Thyroid pp 87-96.